REG - Gattaca PLC - Board Changes

GattacaAnnouncement

24/10/2023 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231024:nRSX0299Ra&default-theme=true

RNS Number : 0299R  Gattaca PLC  24 October 2023

24 October 2023

 

Gattaca plc

 

("Gattaca", the "Group")

 

Board Changes

 

 

Gattaca, the specialist staffing solutions business, announces the following
Board changes which will take effect immediately following the Group's AGM to
be held on the 6 December 2023.

Richard Bradford to succeed Patrick Shanley as Independent Non-Executive Chair

Patrick Shanley, who has been independent Non-Executive Chair of Gattaca since
December 2015, has decided to step down from the Board and he will be replaced
by Richard Bradford as Independent Non-Executive Chair immediately following
the AGM.

Richard has extensive experience in solutions and services businesses, both in
the UK and USA.  He was Chief Executive of AIM quoted Carlisle Group from
1997 to 2008, up to and including its merger with Corporate Services Group to
create Impellam Group.  Richard was previously Chief Executive of LPM Group,
a private equity backed mid-market group of facilities management investments
and began his career with Exel Logistics (now DHL).  He is currently chairman
of UK based InHealth Group, a leading provider of diagnostics and imaging
services, a partner at InHealth Ventures, a London-based transatlantic
early-stage digital healthcare fund and deputy chair of the Independent
Healthcare Providers Network.

Richard was previously a Non-Executive Director at Gattaca, having originally
been appointed in 2011.  Since stepping down from the Board in December 2020,
he has had no involvement with the business, nor has he previously worked
directly with the Group's current Executive directors.  As such, the Board
have concluded it appropriate that Richard be considered independent.

George Materna, founder and largest shareholder, to step down from the Board

George Materna, the Group's founder and largest shareholder, has decided to
retire from the Board and will step down at the AGM.  George founded the
business nearly 40 years ago and has made a major contribution to the Group.
 George has been a Non-Executive Director on the Board for over 15 years. He
has stated his intention to retain his existing shareholding in the Group.

Ros Haith to step down from the Board

In addition, as the number of non-independent members of the Board will reduce
following George Materna's retirement the decision has been taken to further
streamline the Board's composition.  Accordingly, Ros Haith, who joined the
Board in 2021, will step down at the AGM.

This refresh to the Board composition takes place alongside the ongoing
implementation of the business transformation plan, focused on developing the
Group's four key strategic priorities.  Following implementation of these
changes, the Board will comprise Matthew Wragg and Oliver Whittaker as CEO and
CFO respectively, David Lawther and Tracey James as Independent Non-Executive
Directors and led by Richard Bradford as Independent Non-Executive Chair.

Commenting Patrick Shanley, Chair, said:

"Last year we accelerated the changes at Board level with the appointment of
Matt Wragg as CEO and Oliver Whitaker as CFO.  We were able to do so as
succession planning was at the core of our Nomination Committee strategy.
 Both have settled very well into their roles and are one of the main reasons
we feel that now is the right time to reshape the Board to reflect what is
required for the next stage of the Group's development. Passing on the baton
is never easy, but in Richard we have someone who both knows the business well
and can bring a fresh perspective.

"Having founded the business nearly 40 years ago, George felt that as he
turned 70, and given his confidence in the Executives, it was a timely
opportunity to step down. He has made an outstanding contribution to the
business over a very long time. During my time on the Board he has always been
supportive and constructive and acted in the interest of all shareholders. He
will be sorely missed.

"Lastly, we wish to thank Ros Haith who will also step down at the AGM. Ros
has shown her sales pedigree and made a significant contribution to Board
discussions. We wish her well in her future endeavours."

Commenting, Richard Bradford, said:

"I am delighted to be re-joining Gattaca. Since my previous association with
the Group several years ago, I get a strong sense of progress in systems,
people and culture that represent the key ingredients for success.

"Notwithstanding the cyclical nature of the overall staffing sector, the Group
is well placed to grow in the STEM markets it serves.

"I look forward to playing my part in helping to deliver future performance
and development.  I would  like to thank Patrick for his contribution to
shaping the Group over the past eight years, whilst George's legacy and
foundation will never be forgotten. I wish them both well for the future."

Commenting, George Materna, said;

"I founded the business in 1984 and now my primary reason for retiring is that
the Board and current management look to be an elite winning team that is
restoring and improving on the previously successful culture.

"Working alongside some outstanding people who have contributed to and been
important to the success and longevity of the business has been truly
fantastic, I thank them all.

"As stated, I will retain my significant shareholding and I look forward to a
promising future for the business and the people in it."

 

The following disclosures are required regarding the appointment of Richard
James Bradford, aged 60, pursuant to Schedule 2(g) of the AIM Rules for
Companies:

 Current Directorships/Partnerships                       Directorships/Partnerships within last 5 years
 E-Locum Services Limited                                 Gattaca PLC
 Euroclinics (UK) Limited                                 Connect Health Pain Services Holdings Limited
 Inhealth (London) Limited                                Connect Health Pain Services Limited
 Inhealth Group Holdings PLC
 Inhealth Group Limited
 Inhealth Limited
 Inhealth Molecular Imaging Limited
 Inhealth Properties Limited
 Inhealth Reporting Limited
 Medical Imaging Audit and Accreditation Limited
 Preventicum UK Limited
 Vista Diagnostics Limited
 Inhealth Endoscopy Limited
 Inhealth Echotech Limited
 Inhealth Diagnostic & Imaging Limited
 Inhealth Intelligence Limited
 Inhealth Cats Limited
 London Centre for Advanced Diagnostics Limited
 The London Upright MRI Company Limited
 United Open MRI Limited
 Yorkshire Upright MRI Centre Limited
 Independent Healthcare Providers Network (IHPN) Limited
 Inhealth Pathology Limited
 Prime Endoscopy (Bristol) Limited
 Healios Ltd
 Inhealth UK Holdings Limited
 Tac Healthcare Limited
 C7 Health Limited
 Diagnostic World Ltd
 Tac Healthcare Group Ltd
 The Aberdeen Clinic Ltd
 Inhealth Audiology and ENT Limited
 Cardinal Inhealth Ltd
 Inhealth Facilities Management Limited
 Lister Inhealth Limited
 Inhealth Ventures Limited

 

There are no further disclosures required to be made in respect of the
appointment under Schedule 2(g) of the AIM Rules for Companies.

The information contained within this announcement is deemed by the Group to
constitute inside information as stipulated under the Market Abuse Regulations
(EU) No. 596/2014. Upon the publication of this announcement via a Regulatory
Information Service, this inside information is now considered to be in the
public domain.

 

For further information please contact:

 

 Gattaca plc                                 +44 (0) 1489 898989
 Matthew Wragg, Chief Executive Officer

 Oliver Whittaker, Chief Financial Officer

 Liberum Capital Limited (Nomad and Broker)  +44 (0) 20 3100 2000
 Lauren Kettle

 Richard Lindley

 IFC Advisory                                +44 (0)20 3934 6630

 Tim Metcalfe

 Graham Herring

 Florence Chandler

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAFFFFIIILVFIV